InvestorsHub Logo
Followers 9
Posts 2033
Boards Moderated 0
Alias Born 08/26/2010

Re: biopharm post# 61067

Sunday, 02/06/2011 12:31:32 PM

Sunday, February 06, 2011 12:31:32 PM

Post# of 345997
Maybe they don't have the money to buy more shares of peregrine.

All I know is if I knew everything about the company and the prospects were like everyone here is saying, I would find a way to buy more shares. Who doesn't want more money? In addition mgmt and BOD purchasing shares raises the stock price which in return helps the company. Its a win-win situation!

Again the naming of Carlton Johnson saids it all. A naming of a COB definitely could have had a huge impact on the company. No reason to hire a BOD member who as a lawyer was on the board when we lost the lawsuit against China and Epstein and is currently on the verge of a mutiny with another penny stock company which coincendently has some of the same board members as PPHM. However I am sure the board had their reasons for naming him. All imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News